Praxis Precision Medicines, Inc. (NASDAQ: PRAX), a clinical-stage biopharmaceutical company translating genetic insights into the development of therapies for ...
From high-pressure reactors to bitumen tanks and slurry pipelines, petrochemical plants face some of the most challenging ...
The US Department of Commerce (DOC) is tightening export restrictions on electronic design automation (EDA) software for China, shifting from broad bans to case-by-case licensing. Sources indicate ...
As a Fixed Operations Coach, I’ve seen it all when it comes to outside parts sales teams. Some reps are just dropping off donuts and calling it ‘building relationships.’ Others are hitting their ...
MANDAN, N.D. (N.D. MONITOR) - The $300 million trial between Dakota Access Pipeline developer and Greenpeace reached the halfway mark on Monday as the company wrapped up its side of the case. Energy ...
Morton County deputies respond Aug. 31, 2016, to a Dakota Access Pipeline construction site where two protesters used devices to attach themselves to equipment. (Morton County Sheriff’s Office photo) ...
The V842 laser tube cutting system from Voortman cuts small to medium-sized tubes and pipes. It features an automatic centering and clamping system to help ensure alignment and +/- 0.1-mm cut ...
Area school districts have spent recent weeks celebrating the season with a variety of themed activities to get students into the holiday spirit. In a ...
Needham analyst Ami Fadia maintained a Buy rating on Praxis Precision Medicines (PRAX – Research Report) today and set a price target of $151.00. Ami Fadia’s rating is based on a combination of ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback